Under- and over-consumption intermittent TB treatment among rural TB patients in south-west China

International Journal of Tuberculosis and Lung Disease

Volumn 11, Issue 12, 2007, Pages 1345-1351

  Wang, Y Y ^a   Liabsuetrakul, T ^a   Chongsuvivatwong, V ^a   Pungrassami, P ^b   He, C Y ^c   Ren, L J ^d   Yang, H Z ^e  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^b Zonal Tuberculosis Centre 12   (Thailand)

^c KUNMING MEDICAL UNIVERSITY   (China)

^d YUNNAN PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^e Simao Centers for Disease Control and Prevention   (China)

Author keywords

Adherence; China; DOTS; Pill count; Pulmonary tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ADULT; ARTICLE; CHINA; CONTROLLED STUDY; DRUG USE; FEMALE; HUMAN; INTERVIEW; LOWEST INCOME GROUP; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT MONITORING; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE;

ADULT; ANTITUBERCULAR AGENTS; CHINA; CROSS-SECTIONAL STUDIES; DIRECTLY OBSERVED THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PREVALENCE; QUESTIONNAIRES; RURAL POPULATION; TUBERCULOSIS, PULMONARY;

EID: 37549068899     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Burman W J, Cohn D L, Rietmeijer C A, Judson F N, Sbarbaro J A, Reves R R. Nonadherence with directly observed therapy for tuberculosis. Epidemiology and effect on the outcome of treatment. Chest 1997; 111: 1168-1173.
2. Addington W W. Patient adherence: the most serious remaining problem in the control of tuberculosis in the United States. Chest 1979; 76 (Suppl): S741-S743.
3. Fox W. 1983. Adherence of patients and physicians: experience and lessons from tuberculosis-II. BMJ (Clin Res Ed) 1983; 287: 101-105.
4. Wares D F, Singh S, Acharva A K, Dangi R. Non-adherence to tuberculosis treatment in the eastern Tarai of Nepal. Int J Tuberc Lung Dis 2003; 7: 327-335.
5. Sumartojo E. When tuberculosis treatment fails. A social behavioral account of patient adherence. Am Rev Respir Dis 1993; 147: 1311-1320.
6. Paramasivan C N, Venkataraman P. Drug resistance in tuberculosis in India. Indian J Med Res 2004; 120: 377-386.
7. US Centers for Disease Control (CDC). Transmission of multidrug-resistant tuberculosis among immunocompromised persons in a correctional system - New York, 1991. Morb Mortal Wkly Rep 1992; 41: 507-509.
8. World Health Organization. What is DOTS? A guide to understanding the WHO-recommended TB control strategy known as DOTS. WHO/CDS/CPC/TB/99.270. Geneva, Switzerland: WHO, 1999.
9. World Health Organization. A guide for tuberculosis treatment supporters. WHO/CDS/TB/2002.300. Geneva, Switzerland: WHO, 2002.
10. Wilkinson D, Davies G R, Connolly C. Directly observed therapy for tuberculosis in rural South Africa, 1991 through 1994. Am J Public Health 1996; 86: 1094-1097.
11. World Health Organization. Treatment of tuberculosis: guidelines for national programmes. 3rd ed. WHO/CDS/TB/2003. 313. Geneva, Switzerland: WHO, 2003.
12. O'Boyle S J, Power J J, Ibrahim M Y, Watson J P. Factors affecting patient adherence with anti-tuberculosis chemotherapy using the directly observed treatment short-course strategy (DOTS). Int J Tuberc Lung Dis 2002; 6: 307-312.
13. Balbay O, Anakkaya A N, Arbak P, Bilgin C, Erbas M. Which patients are able to adherence to tuberculosis treatment? A study in a rural area in the Northwest part of Turkey. Jpn J Infect Dis 2005; 58: 152-158.
14. Liam C K, Lim K H, Wong C M, Tang B G. Attitudes and knowledge of newly diagnosed tuberculosis patients regarding the disease and factors affecting treatment adherence. Int J Tuberc Lung Dis 1999; 3: 300-309.
15. Mishra P, Hansen E H, Sabroe S, Kafle K K. Adherence is associated with the quality of professional-patient interaction in Directly Observed Treatment Short-course, DOTS. Patient Educ Couns 2006; 63: 29-37.
16. World Health Organization. Global Tuberculosis Database. Geneva, Switzerland: WHO 2007. http://www.who.int/tb/country/global_tb_database/en/ index.html
17. China Tuberculosis Control Collaboration. Results of directly observed short-course chemotherapy in 112 842 Chinese patients with smear-positive tuberculosis. Lancet 1996; 347: 358-362.
18. Xianyi C, Fengzeng Z, Hongjin D, et al. The DOTS strategy in China: results and lessons after 10 years. Bull World Health Organ 2002; 80: 430-436.
19. National Bureau of Statistics of China. Bureau of Statistics of Yunnan Province, 28th April 2001. Kunming, Yunnan, China: National Bureau of Statistics of China, 2007. http://www.stats.gov.cn/tjgb/rkpcgb/dfrkpcgb/t20020331_15405. htm Accessed April 2007.
20. World Health Organization. Sample size determination: a user's manual. WHO/HST/ESM/86/1. Geneva, Switzerland: WHO, 1986.
21. Lertmaharit S, Kamol-Ratankul P, Sawert H, Jittimanee S, Wangmanee S. Factors associated with adherence among tuberculosis patients in Thailand. J Med Assoc Thai 2005; 88 (Suppl): S149-S156.
22. Moulding T S, Caymittes M. Managing medication adherence of tuberculosis patients in Haiti with medication monitors. Int J Tuberc Lung Dis 2002; 6: 313-319.
23. Fallab-Stubi C L, Zellweger J P, Sauty A, Uldry C, Iorillo D, Burnier M. Electronic monitoring of adherence to treatment in the preventive chemotherapy of tuberculosis. Int J Tuberc Lung Dis 1998; 2: 525-530.
24. Sim J, Wright C C. The kappa statistic in reliability studies: use, interpretation, and sample size requirements. Phys Ther 2005; 85: 257-268.
25. Kaona F A, Tuba M, Siziva S, Sikaona L. An assessment of factors contributing to trearment adherence and knowledge of TB transmission among patients on TB treatment. BMC Public Heath 2004; 4: 68.
26. Simao Centres for Disease Control and Prevention. Tuberculosis report in Simao. Simao, Yunnan, China: Simao CDC press release, 2006.
27. Seetha M A, Srikantaramu N, Aneja K S, Singh H. Influence of motivation of patients and their family members on the drug collection by patients. Indian J Tuberc 1981; 28: 182-190.
28. Haynes R B, Taylor D W, Sackett D L, Gibson E S, Bernholz C D, Mukherjee J. Can simple clinical measurements detect patient nonadherence? Hypertension 1980; 2: 757-764.
29. Roth H P, Caron H S, Hsi B P. Measuring intake of a prescribed medication. A bottle count and a tracer technique compared. Clin Pharmacol Ther 1970; 11: 228-237.
30. Roth J K. The pill bottle desiccant and nonadherence. JAMA 1980; 224: 2263.
31. Starr M, Sawyer S, Carlin J, Powell C, Newman R, Johnson P. A novel approach to monitoring adherence to preventive therapy for tuberculosis in adolescence. J Paediatr Child Health 1999; 35: 350-354.
32. Pungrassami P, Johnsen S P, Chongsuvivatwong V, Olsen J, Sorensen H T. Practice of directly observed treatment (DOT) for tuberculosis in southern Thailand: comparison between different types of DOT observers. Int J Tuberc Lung Dis 2002; 6: 389-395.
33. Pungrassami P, Johnsen S P, Chongsuvivatwong V, Olsen J. Has directly observed treatment improved outcomes for patients with tuberculosis in southern Thailand? Trop Med Int Health 2002; 7: 271-279.
34. Balasubramanian V N, Oommen K, Samuel R. DOT or not? Direct observation of anti-tuberculosis treatment and patient outcomes, Kerala State, India. Int J Tuberc Lung Dis 2000; 4: 409-413.
35. Khan M A, Walley J D, Witter S N, Imran A, Safdar N. Cost and cost-effectiveness of different DOT strategies for the treatment of tuberculosis in Pakistan. Health Policy Plan 2002; 17: 178-186.